TY  - GEN
AU  - Carmona-Hidalgo, Beatriz
AU  - García-Martín, Adela
AU  - Muñoz, Eduardo
AU  - González-Mariscal, Isabel
PY  - 2021
DO  - 10.3390/ph14090863
UR  - http://hdl.handle.net/20.500.12105/18448
AB  - Anti-inflammatory and antidiabetogenic properties have been ascribed to cannabidiol (CBD). CBD-based medicinal drugs have been approved for over a lustrum, and a boom in the commercialization of CBD products started in parallel. Herein, we explored...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
KW  - Cannabinoid
KW  - Streptozotocin
KW  - Phytocannabinoid
KW  - Type 1 diabetes
KW  - Endocannabinoid system
KW  - Chronic kidney disease
KW  - Cannabinoides
KW  - Diabetes Mellitus experimental
KW  - Diabetes Mellitus tipo 1
KW  - Endocannabinoides
KW  - Insuficiencia renal crónica
KW  - Mice
KW  - Animals
KW  - Streptozocin
KW  - Diabetic Nephropathies
KW  - Diabetes Mellitus, Experimental
KW  - Blood Glucose
KW  - Cannabidiol
KW  - Diabetes Mellitus, Type 1
KW  - Glucose Intolerance
KW  - Insulin-Secreting Cells
KW  - Kidney
KW  - Hyperglycemia
TI  - Detrimental Effect of Cannabidiol on the Early Onset of Diabetic Nephropathy in Male Mice
TY  - research article
ER  -